Gilmartin Capital

Gilmartin Capital is a specialized healthcare investment firm backing early-stage companies. It invests in platforms addressing critical medical challenges: underserved diseases, scientific discovery, and efficient healthcare delivery. Opportunities beyond proof of concept in medical device, life science tool, diagnostic, and digital health are targeted, enhanced by domain expertise and capital markets advisory.

The firm was founded by David Lewis and Jonathan Demchick, leveraging extensive careers in healthcare equity research and investment banking. Lewis led Morgan Stanley’s medical technology equity practice for fifteen years. Demchick, a Co-Founder, held key roles at Millennium Management and Morgan Stanley. Their insight identified a need for specialized guidance and strategic capital in emerging healthcare ventures.

Gilmartin Capital partners with entrepreneurs developing disruptive medical technologies. Its mission is to guide innovators, offering resources to propel advancements and foster growth. The firm aims to help portfolio companies achieve full potential, advancing healthcare technology and patient care.